Myocarditis Post Vaccination or Multi System Inflammatory Syndrome

Status Recruiting

Clinical Trial Summary

BNT162b2 vaccine has become one of the most prevalent vaccines against the COVID-19 and is currently the main vaccine used in Israel. Since marketing and the beginning of use of the vaccine, we and others have reported. of the development of post vaccination myocarditis. In this study the investigators wish to explore the long term impact on 150 patients who have been diagnosed with myocarditis or multisystem inflammatory syndrome (MIS) in the year following their diagnosis of Myocarditis.

Clinical Trial Description

Aim of Study The primary aim of the study is to evaluate the impact of long term impact of myocarditis which has been developed secondary to Covid 19 vaccine or Covid 19 infection. The primary end points of the study will be functional evaluations of the patients using clinical evaluation that includes questionnaires, ECG findings, evaluation of the systolic and diastolic function of the heart using echocardiogram or cardiac MRI, laboratory tests including troponin, CPK, CRP, Pro-BNP, and cytokines/chemokines. Methods In this prospective study patients will be recruited from health care providers The selected patients will come to Hadassah hospital within 6 and 12 months after they have been diagnosed with myocarditis. Upon the patients arrival they will sign the informed consent, the investigators will draw blood tests and the participants will perform an echocardiogram according to the special protocol and will perform cardiac- MRI according to the myocarditis protocol. Patients will fulfill health questionnaires. that may include 36 Health Survey Questionnaire (SF-36); Scores on the European Quality of Life-5 Dimensions (EQ-5D) survey, which is also health-related quality of life score; the Scores on the European Quality of Life Visual Analogue Scale (EQ-VAS); Kansas City Cardiomyopathy Questionnaire (KCCQ). the Investigators will obtain blood samples from all the patients: complete blood count, c- reactive protein, troponin, CPK, Pro-BNP, liver and kidney functions, magnesium and cytokines. In addition, all participants will undergo echocardiogram test to evaluate their systolic and diastolic function of the heart. Ethical Considerations The study poses no danger to the participants. It has the potential to improve the understanding of the impact myocarditis post COVID-19 MRNA vaccine on the quality of life of those patients and provide a descent follow-up for the participant. Any participant will sign on informed consent form. ;

Study Design

Related Conditions & MeSH terms

Myocarditis

Clinical Trial Details

NCT number	NCT05288426
Study type	Observational
Source	Hadassah Medical Organization
Contact	Dror Mevorach, MD
Phone	972-2- 6777317
Email	mevorachd@hadassah.org.il
Status	Recruiting
Phase
Start date	November 1, 2021
Completion date	December 1, 2025

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT05911386` - Multiparametric Echocardiography and Cardiac Biomarkers in Pediatric Inflammatory Heart Diseases
Not yet recruiting	`NCT04085718` - FDG-PET/CT Images Comparing to MRI and Endomyocardial Biopsy in Myocarditis
Enrolling by invitation	`NCT05610423` - Covid-19 Vaccine Associated Myocarditis and Pericarditis in Norway
Active, not recruiting	`NCT05195645` - AbataCept for the Treatment of Immune-cHeckpoint Inhibitors Induced mYocarditiS	Phase 2
Recruiting	`NCT05184114` - Clinical Significance of Subclinical Myocardial Involvement in Recovered COVID-19 Patients Using Cardiovascular Magnetic Resonance	N/A
Recruiting	`NCT04612296` - The Heart Hive - Cardiomyopathy Study
Recruiting	`NCT04673409` - CMR Imaging of Autoimmune Diseases
Recruiting	`NCT05295290` - A Study to Learn About The COVID-19 (Study) Vaccine (Called COMIRNATY) in People That Are Less Than 21 Years Old.	Phase 4
Completed	`NCT03777839` - PET-FDG in Myocarditis
Completed	`NCT06447935` - Acute Eosinophilic Myocarditis International Registry
Not yet recruiting	`NCT05125965` - Contribution of Cardiac MRI in the Early Diagnosis of Myocarditis Induced by Immunotherapy	N/A
Active, not recruiting	`NCT04444128` - IMPRoving Cardiovascular RiSk Stratification Using T1 Mapping in General populatION
Recruiting	`NCT06158698` - CMP-MYTHiC Trial and Registry - CardioMyoPathy With MYocarditis THerapy With Colchicine	Phase 3
Recruiting	`NCT05282498` - Pathophysiologic Mechanism for MYOcarditis in COVID19 VAccinations ("MYOVAx" Study)
Recruiting	`NCT03801681` - ARrhythmias in MYocarditis
Recruiting	`NCT06116084` - Randomized Controlled Study Evaluating the Efficacy of Hypnosis in Nuclear Medicine	N/A
Completed	`NCT04413071` - Cardiac COVID-19 Health Care Workers
Recruiting	`NCT05414162` - Multiparametric Cardiac MRI in Patients Under CAR T-cell Therapy
Recruiting	`NCT06409585` - Cardiomyopathies and Heart Muscle Diseases: Cardiac Imaging in the Evaluation of Myocardial Fibrosis Transition
Completed	`NCT02299856` - Cardiac Magnetic Resonance in Acute Myocarditis	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Myocarditis Post Vaccination or Multi System Inflammatory Syndrome — MyoVax

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms